479 related articles for article (PubMed ID: 26338970)
61. Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways.
Fortschegger K; Husa AM; Schinnerl D; Nebral K; Strehl S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299194
[TBL] [Abstract][Full Text] [Related]
62. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.
Duque-Afonso J; Smith KS; Cleary ML
PLoS One; 2015; 10(11):e0143216. PubMed ID: 26588248
[TBL] [Abstract][Full Text] [Related]
63. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
[TBL] [Abstract][Full Text] [Related]
64. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation.
Hoelbl A; Kovacic B; Kerenyi MA; Simma O; Warsch W; Cui Y; Beug H; Hennighausen L; Moriggl R; Sexl V
Blood; 2006 Jun; 107(12):4898-906. PubMed ID: 16493008
[TBL] [Abstract][Full Text] [Related]
65. Loss of Bcl-x in Ph+ B-ALL increases cellular proliferation and does not inhibit leukemogenesis.
Harb JG; Chyla BI; Huettner CS
Blood; 2008 Apr; 111(7):3760-9. PubMed ID: 18216295
[TBL] [Abstract][Full Text] [Related]
66. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
Heltemes-Harris LM; Willette MJ; Ramsey LB; Qiu YH; Neeley ES; Zhang N; Thomas DA; Koeuth T; Baechler EC; Kornblau SM; Farrar MA
J Exp Med; 2011 Jun; 208(6):1135-49. PubMed ID: 21606506
[TBL] [Abstract][Full Text] [Related]
67. Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation.
Zhang J; Wang J; Liu Y; Sidik H; Young KH; Lodish HF; Fleming MD
Blood; 2009 Feb; 113(6):1304-14. PubMed ID: 19066392
[TBL] [Abstract][Full Text] [Related]
68. Hepatic Leukemia Factor Maintains Quiescence of Hematopoietic Stem Cells and Protects the Stem Cell Pool during Regeneration.
Komorowska K; Doyle A; Wahlestedt M; Subramaniam A; Debnath S; Chen J; Soneji S; Van Handel B; Mikkola HKA; Miharada K; Bryder D; Larsson J; Magnusson M
Cell Rep; 2017 Dec; 21(12):3514-3523. PubMed ID: 29262330
[TBL] [Abstract][Full Text] [Related]
69. MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
Sochalska M; Schuler F; Weiss JG; Prchal-Murphy M; Sexl V; Villunger A
Oncogene; 2017 Apr; 36(15):2066-2073. PubMed ID: 27694901
[TBL] [Abstract][Full Text] [Related]
70. CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation.
Lawson H; van de Lagemaat LN; Barile M; Tavosanis A; Durko J; Villacreces A; Bellani A; Mapperley C; Georges E; Martins-Costa C; Sepulveda C; Allen L; Campos J; Campbell KJ; O'Carroll D; Göttgens B; Cory S; Rodrigues NP; Guitart AV; Kranc KR
Stem Cell Reports; 2021 Nov; 16(11):2784-2797. PubMed ID: 34715054
[TBL] [Abstract][Full Text] [Related]
71. The histone lysine acetyltransferase HBO1 (KAT7) regulates hematopoietic stem cell quiescence and self-renewal.
Yang Y; Kueh AJ; Grant ZL; Abeysekera W; Garnham AL; Wilcox S; Hyland CD; Di Rago L; Metcalf D; Alexander WS; Coultas L; Smyth GK; Voss AK; Thomas T
Blood; 2022 Feb; 139(6):845-858. PubMed ID: 34724565
[TBL] [Abstract][Full Text] [Related]
72. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
[TBL] [Abstract][Full Text] [Related]
73. Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
Xiao W; Hong H; Kawakami Y; Kato Y; Wu D; Yasudo H; Kimura A; Kubagawa H; Bertoli LF; Davis RS; Chau LA; Madrenas J; Hsia CC; Xenocostas A; Kipps TJ; Hennighausen L; Iwama A; Nakauchi H; Kawakami T
Cancer Cell; 2009 Aug; 16(2):161-71. PubMed ID: 19647226
[TBL] [Abstract][Full Text] [Related]
74. Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.
Fatrai S; Wierenga AT; Daenen SM; Vellenga E; Schuringa JJ
Blood; 2011 Mar; 117(12):3320-30. PubMed ID: 21263150
[TBL] [Abstract][Full Text] [Related]
75. Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
Mattes K; Geugien M; Korthuis PM; Brouwers-Vos AZ; Fehrmann RSN; Todorova TI; Steidl U; Vellenga E; Schepers H
Exp Hematol; 2019 May; 73():38-49.e7. PubMed ID: 30986495
[TBL] [Abstract][Full Text] [Related]
76. The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene.
Wang PY; Young F; Chen CY; Stevens BM; Neering SJ; Rossi RM; Bushnell T; Kuzin I; Heinrich D; Bottaro A; Jordan CT
Blood; 2008 Nov; 112(10):4184-92. PubMed ID: 18755985
[TBL] [Abstract][Full Text] [Related]
77. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
Luo H; Li Q; O'Neal J; Kreisel F; Le Beau MM; Tomasson MH
Blood; 2005 Oct; 106(7):2452-61. PubMed ID: 15972450
[TBL] [Abstract][Full Text] [Related]
78. The chromatin remodeling subunit Baf200 promotes normal hematopoiesis and inhibits leukemogenesis.
Liu L; Wan X; Zhou P; Zhou X; Zhang W; Hui X; Yuan X; Ding X; Zhu R; Meng G; Xiao H; Ma F; Huang H; Song X; Zhou B; Xiong S; Zhang Y
J Hematol Oncol; 2018 Feb; 11(1):27. PubMed ID: 29482581
[TBL] [Abstract][Full Text] [Related]
79. Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.
Weidemann RR; Behrendt R; Schoedel KB; Müller W; Roers A; Gerbaulet A
Exp Hematol; 2017 Jan; 45():45-55.e6. PubMed ID: 27664314
[TBL] [Abstract][Full Text] [Related]
80. Endothelial protein C receptor supports hematopoietic stem cell engraftment and expansion in Mpl-deficient mice.
Kohlscheen S; Schenk F; Rommel MGE; Cullmann K; Modlich U
Blood; 2019 Mar; 133(13):1465-1478. PubMed ID: 30683655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
